• Home
  • About Steve Woodruff
  • Contact
  • Let’s Talk!
  • About Impactiviti

Impactiviti blog

Best Practices in Vendor and Project Management

Feeds:
Posts
Comments
« Impactiviti Daily 030110
Impactiviti Daily 030810 »

Impactiviti Daily 030510

March 5, 2010 by Steve Woodruff

*****

TODAY’S NEWS

New blood thinner looking good; superior to Lovenox? – Bristol-Myers Squibb Co.’s and Pfizer Inc.’s experimental blood thinner prevented dangerous blood clots from forming after knee replacement surgery better than Sanofi-Aventis’s Lovenox in a European study. The company-funded trial, dubbed Advance-2, found patients given apixaban pills twice daily were 38 percent less likely to develop clots deep in the legs, in the lungs or die within two weeks than those given intravenous Lovenox starting before the operation. People in both groups had a similar risk of bleeding, a feared complication of blood-thinning medications. SA..more BMS is talking about 60 drugs in testing phase these days…

Eisai‘s sales to go down by more than half – Japan’s No.4 drugmaker, said it expects annual U.S. sales of its flagship Alzheimer’s drug Aricept to fall 60 percent in three years, hit by the expiration of the drug’s patent later this year…more

The 10 scariest pharma and healthcare YouTube videos. From Dose of Digital blog.

Need new sales reps? Poach.

RECOMMENDED

Social Media Strategy/Execution – If you’re looking to employ social media in pharma communications/marketing, a thousand providers will tell you they can help. But who is really the best for your needs?. We’ve got the partners you need in the Impactiviti network. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.

PLUS

Tearing up the rule book on pharma sales force compensation (from Pharmaceutical Executive). And survey says: the glory days aren’t coming back.

JUST FOR FUN

What are “crepuscular rays”? You’ll recognize them when you see them! 20 gorgeous examples.

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Visit the Impactiviti Job Board

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

***

Advertisements

Share this:

  • Twitter
  • Facebook
  • Email

Like this:

Like Loading...

Posted in BMS, Bristol Myers, Pfizer, Pharma, Pharma News, Pharmaceutical, Sanofi-Aventis, Social Media, Top News | Tagged Apixaban, aricept, Eisai |

  • Welcome!


    Steve Woodruff
    sw
    President, Impactiviti
  • Testimonials


    “Steve Woodruff is one of the most “networked” people I’ve found in pharmaceutical training. His communications are always smart and targeted, and I value his professional partnership.” -Jennifer Zinn, Director, Worldwide Marketing, Clinical Laboratory, Ortho Clinical Diagnostics

    Read More Testimonials
  • Subscribe to our e-newsletter

    Sign up for the Impactiviti Connection!
  • Subscribe to the blog!

    Subscribe in a reader
  • Subscribe via e-mail

    Subscribe to Impactiviti blog by Email
  • Recent Posts

    • Try Out the Random Vendor Generator!
    • Clocks, Toddlers, and Project Management
    • What are you delivering (via LMS)?
    • Today’s Pharma News 8/18/2017
    • Today’s Pharma News 8/16/17
    • Today’s Pharma News 8/15/17
    • Today’s Pharma News (8/14/17)
    • Lighting “afar” in Nashville – LTEN 2017 re-cap
    • Let’s Stop Committing Training Malpractice!
    • Getting Ready for Nashville 1-2-3-4!
  • Archives

    • November 2017
    • October 2017
    • August 2017
    • June 2017
    • May 2017
    • April 2017
    • March 2017
    • February 2017
    • January 2017
    • December 2016
    • November 2016
    • October 2016
    • June 2016
    • April 2016
    • March 2016
    • February 2016
    • January 2016
    • December 2015
    • November 2015
    • October 2015
    • September 2015
    • August 2015
    • July 2015
    • June 2015
    • May 2015
    • April 2015
    • March 2015
    • February 2015
    • January 2015
    • December 2014
    • October 2014
    • September 2014
    • August 2014
    • July 2014
    • June 2014
    • May 2014
    • April 2014
    • March 2014
    • February 2014
    • January 2014
    • November 2013
    • October 2013
    • September 2013
    • August 2013
    • July 2013
    • June 2013
    • May 2013
    • April 2013
    • March 2013
    • February 2013
    • January 2013
    • December 2012
    • November 2012
    • October 2012
    • September 2012
    • July 2012
    • June 2012
    • May 2012
    • April 2012
    • March 2012
    • February 2012
    • January 2012
    • December 2011
    • November 2011
    • October 2011
    • September 2011
    • August 2011
    • July 2011
    • June 2011
    • May 2011
    • April 2011
    • March 2011
    • February 2011
    • January 2011
    • December 2010
    • November 2010
    • October 2010
    • September 2010
    • August 2010
    • July 2010
    • June 2010
    • May 2010
    • April 2010
    • March 2010
    • February 2010
    • January 2010
    • December 2009
    • November 2009
    • October 2009
    • September 2009
    • August 2009
    • July 2009
    • June 2009
    • May 2009
    • April 2009
    • March 2009
    • February 2009
    • January 2009
    • December 2008
    • November 2008
    • October 2008
    • September 2008
    • August 2008
    • July 2008
    • June 2008
    • May 2008
    • April 2008
    • March 2008
    • February 2008
    • January 2008
    • December 2007
    • November 2007
    • October 2007
    • September 2007
    • August 2007
    • July 2007
    • June 2007
    • May 2007
    • April 2007
    • March 2007
    • February 2007
    • January 2007
    • December 2006
    • November 2006
    • October 2006
    • September 2006
    • August 2006
    • July 2006
  • Advertisements

Blog at WordPress.com.

WPThemes.


Cancel
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
%d bloggers like this: